Acute activation of Erk1/Erk2 and protein kinase B/akt proceed by independent pathways in multiple cell types

FEBS Journal

Volumn 272, Issue 17, 2005, Pages 4372-4384

  Chiu, Doris ^a   Ma, Kewei ^a   Scott, Alexander ^a   Duronio, Vincent ^a,b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b JACK BELL RESEARCH CENTRE   (Canada)

Author keywords

Cross talk; Cytokine; Inhibitors; Kinase; Phosphorylation

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 MORPHOLINO 8 PHENYLCHROMONE; CYTOKINE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PROTEIN KINASE B; THREONINE; TYROSINE; WORTMANNIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; B LYMPHOCYTE; CELL CULTURE; CELL STIMULATION; CELL STRAIN HEK293; CELL SURVIVAL; CELL TYPE; CONTROLLED STUDY; DRUG POTENTIATION; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; FIBROBLAST; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; MOLECULAR INTERACTION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANDROSTADIENES; ANIMALS; APOPTOSIS; B-LYMPHOCYTES; CELL LINE; CELLS, CULTURED; CHROMONES; ENZYME ACTIVATION; HUMANS; MAP KINASE SIGNALING SYSTEM; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MORPHOLINES; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTOR CROSS-TALK; SWINE;

EID: 24644463827     PISSN: 1742464X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1742-4658.2005.04850.x     Document Type: Article

References (51)

1. English J, Pearson G, Wilsbacher J, Swantek J, Karandikar M, Xu S & Cobb MH (1999) New insights into the control of MAP kinase pathways. Exp Cell Res 253, 25-270.
2. Brunet A & Pouyssegur J (1997) Mammalian MAP kinase modules: how to transduce specific signals. Essays Biochem 32, 1-16.
3. Fruman DA, Meyers RE & Cantley LC (1998) Phosphoinositide kinases. Annu Rev Biochem 67, 481-507.
4. Martin TFJ (1998) Phosphoinositide lipids as signaling molecules: common themes for signal transduction, cytoskeletal regulation, and membrane trafficking. Annu Rev Cell Dev Biol 14, 231-264.
5. Duronio V, Scheid MP & Ettinger S (1998) Downstream signalling events regulated by phosphatidylinositol 3-kinase activity. Cell Signal 10, 233-239.
6. Standaert ML, Bandyopadhyay G & Farese RV (1995) Studies with wortmannin suggest a role for phosphatidylinositol 3-kinase in the activation of glycogen synthase and mitogen-activated protein kinase by insulin in rat adipocytes: comparison of insulin and protein kinase C modulators. Biochem Biophys Res Commun 209, 1082-1088.
7. Von Willebrand M, Jascur T, Bonnefoy-Berard N, Yano H, Altman A, Matsuda Y & Mustelin T (1996) Inhibition of phosphatidylinositol 3-kinase blocks T cell antigen receptor/CD3-induced activation of the mitogen-activated kinase Erk2. Eur J Biochem 235, 828-835.
8. Grammer TC & Blenis J (1997) Evidence for MEK-independent pathways regulating the prolonged activation of the ERK-MAP kinases. Oncogene 14, 1635-1642.
9. Bondeva T, Pirola L, Bulgarelli-Leva G, Rubio I, Wetzker R & Wymann MP (1998) Bifurcation of lipid and protein kinase signals of PI3Kgamma to the protein kinases PKB and MAPK. Science 282, 293-296.
10. Sutor SL, Vroman BT, Armstrong EA, Abraham RT & Karnitz LM (1999) A phosphatidylinositol 3-kinase-dependent pathway that differentially regulates c-Raf and A-Raf. J Biol Chem 274, 7002-7010.
11. Wandzioch E, Edling CE, Palmer RH, Carlsson L & Hallberg B (2004) Activation of the MAP kinase pathway by c-Kit is PI-3 kinase dependent in hematopoietic progenitor/stem cell lines. Blood 104, 51-57.
12. Cheatham B, Vlahos CJ, Cheatham L, Wang L, Blenis J & Kahn CR (1994) Phosphatidylinositol 3-kinase activation is required for insulin stimulation of pp70, S6 kinase, DNA synthesis, and glucose transporter translocation. Mol Cell Biol 14, 4902-4911.
13. Scheid MP & Duronio V (1996) Phosphatidylinositol 3-OH kinase activity is not required for activation of mitogen-activated protein kinase by cytokines. J Biol Chem 271, 18134-18139.
14. Frevert EU & Kahn BB (1997) Differential effects of constitutively active phosphatidylinositol 3-kinase on glucose transport, glycogen synthase activity, and DNA synthesis in 3T3-L1 adipocytes. Mol Cell Biol 17, 190-198.
15. Coffer PJ, Jin J & Woodgett JR (1998) Protein kinase B (c-Akt): a multifunctional mediator of phosphatidylinositol 3-kinase activation. Biochem J 335, 1-13.
16. Scheid MP & Woodgett JR (2001) PKB/AKT: functional insights from genetic models. Nat Rev Mol Cell Biol 2, 760-768.
17. Yang J, Cron P, Thompson V, Good VM, Hess D, Hemmings BA & Barford D (2002) Molecular mechanism for the regulation of protein kinase B/Akt by hydrophobic motif phosphorylation. Mol Cell 9, 1227-1240.
18. Delcommenne M, Tan C, Gray V, Rue L, Woodgett J & Dedhar S (1998) Phosphoinositide-3-OH kinase-dependent regulation of glycogen synthase kinase 3 and protein kinase B/AKT by the integrin-linked kinase. Proc Natl Acad Sci USA 95, 11211-11216.
19. Feng J, Park J, Cron P, Hess D & Hemmings BA (2004) Identification of a PKB/Akt hydrophobic motif Ser-473 kinase as DNA-dependent protein kinase. J Biol Chem 279, 41189-41196.
20. Kauffmann-Zeh A, Rodriguez-Viciana P, Ulrich E, Gilbert C, Coffer P, Downward J & Evan G (1997) Suppression of c-Myc-induced apoptosis by Ras signalling through PI(3)K and PKB. Nature 385, 544-548.
21. Gold MR, Duronio V, Saxena SP, Schrader JW & Aebersold R (1994) Multiple cytokines activate phosphatidylinositol 3-kinase in hemopoietic cells. Association of the enzyme with various tyrosine-phosphorylated proteins. J Biol Chem 269, 5403-5412.
22. Karnitz LM, Burns LA, Sutor SL, Blenis J & Abraham RT (1995) Interleukin-2 triggers a novel phosphatidylinositol 3-kinase-dependent MEK activation pathway. Mol Cell Biol 15, 3049-3057.
23. Craddock BL, Hobbs J, Edmead CE & Welham MJ (2001) Phosphoinositide 3-kinase-dependent regulation of interleukin-3-induced proliferation: involvement of mitogen-activated protein kinases, SHP2 and Gab2. J Biol Chem 276, 24274-24283.
24. Rommel C, Clarke BA, Zimmermann S, Nunez L, Rossman R, Reid K, Moelling K, Yancopoulos GD & Glass DJ (1999) Differentiation stage-specific inhibition of the Raf-MEK-ERK pathway by Akt. Science 286, 1738-1741.
25. Zimmermann S & Moelling K (1999) Phosphorylation and regulation of Raf by Akt (protein kinase B). Science 286, 1741-1744.
26. Jacob A, Cooney D, Pradhan M & Coggeshall KM (2002) Convergence of signaling pathways on the activation of ERK in B cells. J Biol Chem 277, 23420-23426.
27. Kitamura T, Tange T, Terasawa T, Chiba S, Kuwaki T, Miyagawa K, Piao YF, Miyazono K, Urabe A & Takaku F (1989) Establishment and characterization of a unique human cell line that proliferates dependently on GM-CSF, IL-3, or erythropoietin. J Cell Physiol 140, 323-334.
28. Duckworth BC & Cantley LC (1997) Conditional inhibition of the mitogen-activated protein kinase cascade by wortmannin. Dependence on signal strength. J Biol Chem 272, 27665-27670.
29. Wennstrom S & Downward J (1999) Role of phosphoinositide 3-kinase in activation of ras and mitogen-activated protein kinase by epidermal growth factor. Mol Cell Biol 19, 4279-4288.
30. Palacios R & Steinmetz M (1985) IL-3-dependent mouse clones that express B-220 surface antigen, contain Ig genes in germ-line configuration, and generate B lymphocytes in vivo. Cell 41, 727-734.
31. Niiro H & Clark EA (2002) Regulation of B-cell fate by antigen-receptor signals. Nat Rev Immunol 2, 945-956.
32. Gold MR, Ingham RJ, McLeod SJ, Christian SL, Scheid MP, Duronio V, Santos L & Matsuuchi L (2000) Targets of B-cell antigen receptor signaling: the phosphatidylinositol 3-kinase/Akt/glycogen synthase kinase-3 signaling pathway and the Rap1 GTPase. Immunol Rev 176, 47-68.
33. Kurosaki T (1999) Genetic analysis of B cell antigen receptor signaling. Annu Rev Immunol. 17, 555-592.
34. Li ZM, Wahl MI, Eguinoa A, Stephens LR, Hawkins PT & Witte ON (1997) Phosphatidylinositol 3-kinase-gamma activates Bruton's tyrosine kinase in concert with Src family kinases. Proc Natl Acad Sci USA 94, 13820-13825.
35. 2+ following B-cell receptor activation. EMBO J 17, 1973-1985.
36. 2-terminal kinase, and p38 mitogen-activated protein kinase activation by the B cell antigen receptor. J Exp Med 188, 1287-1295.
37. Reusch HP, Zimmermann S, Schaefer M, Paul M & Moelling K (2001) Regulation of Raf by Akt controls growth and differentiation in vascular smooth muscle cells. J Biol Chem 276, 33630-33637.
38. Rommel C, Clarke BA, Zimmermann S, Nunez L, Rossman R, Reid K, Moelling K, Yancopoulos GD & Glass DJ (1999) Differentiation stage-specific inhibition of the Raf-MEK-ERK pathway by Akt. Science 286, 1738-1741.
39. Tsakiridis T, Tsiani E, Lekas P, Bergman A, Cherepanov V, Whiteside C & Downey GP (2001) Insulin, insulin-like growth factor-I, and platelet-derived growth factor activate extracellular signal-regulated kinase by distinct pathways in muscle cells. Biochem Biophys Res Commun 288, 205-211.
40. Yao R & Cooper GM (1995) Requirement for phosphatidylinositol-3 kinase in the prevention of apoptosis by nerve growth factor. Science 267, 2003-2006.
41. Minshall C, Arkins S, Freund GG & Kelley KW (1996) Requirement for phosphatidylinositol 3′-kinase to protect hemopoietic progenitors against apoptosis depends upon the extracellular survival factor. J Immunol 156, 939-947.
42. Vemuri GS & McMorris FA (1996) Oligodendrocytes and their precursors require phosphatidylinositol 3-kinase signaling for survival. Development Suppl 122, 2529-2537.
43. Franke TF, Kaplan DR & Cantley LC (1997) PI3K: downstream AKTion blocks apoptosis. Cell 88, 435-437.
44. Downward J (1998) Mechanisms and consequences of activation of protein kinase B/Akt. Curr Opin Cell Biol 10, 262-267.
45. Scheid MP, Lauener RW & Duronio V (1995) Role of phosphatidylinositol 3-OH-kinase activity in the inhibition of apoptosis in haemopoietic cells: phosphatidylinositol 3-OH-kinase inhibitors reveal a difference in signalling between interleukin-3 and granulocyte-macrophage colony stimulating factor. Biochem J 312, 159-162.
46. Favata MF, Horiuchi KY, Manos EJ, Daulerio AJ, Stradley DA, Feeser WS, Van Dyk DE, Pitts WJ, Earl RA, Hobbs F et al. (1998) Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J Biol Chem 273, 18623-18632.
47. Ballif BA & Blenis J (2001) Molecular mechanisms mediating mammalian mitogen-activated protein kinase (MAPK) kinase (MEK)-MAPK cell survival signals. Cell Growth Differ 12, 397-408.
48. 2 activity in Swiss 3T3 cells. Wortmannin is not a specific inhibitor of phosphatidylinositol 3-kinase. J Biol Chem 270, 25352-25355.
49. Brunn GJ, Williams J, Sabers C, Wiederrecht G, Lawrence JC Jr & Abraham RT (1996) Direct inhibition of the signaling functions of the mammalian target of rapamycin by the phosphoinositide 3-kinase inhibitors, wortmannin and LY294002. EMBO J 15, 5256-5267.
50. Davies SP, Reddy H, Caivano M & Cohen P (2000) Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem J 351, 95-105.
51. Schubert KM & Duronio V (2001) Distinct roles for extracellular-signal-regulated protein kinase (ERK) mitogen-activated protein kinases and phosphatidylinositol 3-kinase in the regulation of Mc1-1 synthesis. Biochem J 356, 473-480.